14 March 2021>: Clinical Research
Association of Hydrogen Sulfide with Femoral Bone Mineral Density in Osteoporosis Patients: A Preliminary Study
Yan-Ming Hao 1ACDE* , Da-Wei He 2BD* , Yan Gao 1BCF* , Ling-Na Fang 3E , Pan-Pan Zhang 4BC , Ke Lu 1BC , Rong-Zhu Lu 2B , Chong Li 5AEFG*DOI: 10.12659/MSM.929389
Med Sci Monit 2021; 27:e929389
Table 1 Clinical characteristics of the study participants.
Variables | Control (n=75) | Osteopenia (n=16) | Osteoporosis (n=9) | P value |
---|---|---|---|---|
Age | 50.2±1.1 | 55.6±1.5* | 79.2±3.1* | 0.045 |
Male/Female | 58/17 | 10/6 | 2/7 | 0.041 |
BMD (lumbar spine) | 1.23±0.11 | 1.01±0.12* | 0.76±0.04* | 0.012 |
BMD (femoral neck) | 0.97±0.08 | 0.78±0.06* | 0.54±0.02* | 0.011 |
T value (lumbar spine) | 0.66±0.12 | −1.59±0.10* | −2.6±0.32* | 0.008 |
T value (femoral neck) | 0.64±0.12 | −1.44±0.11* | −3.17±0.18* | 0.005 |
Values are expressed as mean±SD. * P # P The gender in three groups was analyzed using χ test, other variables in three groups was analyzed one-way analysis of variance. |